Fig. 1From: The role of interleukin-33 in patients with mild cognitive impairment and Alzheimer’s diseasePatients with aMCI or AD had higher proportion of peripheral IL-33 expression with linear trend. Pearson’s Chi-Square test: P = 0.002; Cochran–Armitage test for linear trend analysis: P < 0.001. Abbreviations: aMCI amnestic mild cognitive impairment, AD Alzheimer’s disease, HC healthy controls, IL interleukinBack to article page